✦ LIBER ✦

Evaluation of Monoclonal Humanized Anti-HER2 Antibody, Trastuzumab, in Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Carcinoma With Overexpression of HER2: A Phase II Trial of the Gynecologic Oncology Group

✍ Scribed by Bookman, M. A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of trastuzumab in women w

✍ Gini F. Fleming; Michael W. Sill; Kathleen M. Darcy; D. Scott McMeekin; J. Tate 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 477 KB

In Re: Re: “Phase II trial of trastuzuma

✍ Michael W. Sill; Gini Fleming 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Phase II evaluation of dasatinib in the

✍ Russell J. Schilder; William E. Brady; Heather A. Lankes; James V. Fiorica; Mark 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 205 KB

A phase II evaluation of lapatinib in th

✍ Agustin A. Garcia; Michael W. Sill; Heather A. Lankes; Andrew K. Godwin; Robert 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 220 KB

A phase II evaluation of AMG 102 (rilotu

✍ Martin, Lainie P.; Sill, Michael; Shahin, Mark S.; Powell, Matthew; DiSilvestro, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 246 KB

A phase II evaluation of belinostat and

✍ Don S. Dizon; John A. Blessing; Richard T. Penson; Richard D. Drake; Joan L. Wal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 197 KB